explore -WSS

explore

author：leisure time 2025-09-27 22:18:37 - browse：2128

Gene therapy helped Conner Curran, right, walk, but as the drug fades, his family is supporting scientific efforts to allow him and other boys get a second dose. -- Biotech coverage from STAT — Gene therapy helped Conner Curran (at right) walk, but as the drug fades, his family is supporting scientific efforts to allow him and other boys get a second dose. Courtesy Jess & Chris Curran

In the beginning, Conner Curran ran up the stairs.

It was a miraculous moment for him and his parents, Jess and Chris Curran. Just months before, contractors were in their New York home to install a motorized lift, while Jess tearfully explained that it wasn’t for a grandparent but for their 7-year-old son, who suffered from Duchenne muscular dystrophy and could barely haul himself up the steps.

Then Conner was accepted as the first patient in Pfizer’s Duchenne gene therapy trial. Three weeks later, he could bound to the second floor. Soon, he could walk the two-plus miles to Goldberg’s, a local bagel shop. “I couldn’t do that before,” he told NPR in 2020.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： New air purifier tech could be key to improving indoor air quality
Next article： Can medical device makers keep up in the race to treat obesity?

knowledge

Wikipedia

WSS

As pharma fights Medicare drug negotiation, hospitals, docs silent

Why more medical students aren't specializing in primary care

How a symptom of dementia informs our understanding of creativity

Xenotransplantation trials will require adjusting expectations, experts say

Radiation, mainstay of cancer treatment, begins a fade

AstraZeneca bets AAV gene therapy will still deliver the goods

Wikipedia

explore

entertainment

Duchenne breakthrough therapy leaves behind pioneering families

A public health expert passes on football's full body collisions for youths

Apple is now the first public company to be valued at $3 trillion

Drug firms test therapies to halt Alzheimer’s before symptoms arise

Affirmative action in medical school literally saved lives

FDA approves first new drug developed for postpartum depression

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

AstraZeneca challenges Medicare drug negotiation program

Guidelines to prevent youth baseball injuries need more muscle

Sea level rise could wash away turtle breeding grounds around the world, researchers say

entertainment

Living organ donors deserve priority status for transplants

Bispecific antibodies are next new thing in cancer immunotherapy

A public health expert passes on football's full body collisions for youths

Over 1,300 arrested in France in 4th night of protests over fatal police shooting of teen Nahel M.

Millions may soon lose Medicaid when they don't have to

Drug firms test therapies to halt Alzheimer’s before symptoms arise

knowledge

Wikipedia

leisure time

Wikipedia